| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 20 | 2020 | 481 | 3.470 |
Why?
|
| Carcinoma, Renal Cell | 10 | 2021 | 435 | 1.250 |
Why?
|
| Mutation | 27 | 2021 | 4132 | 1.250 |
Why?
|
| Biomarkers, Tumor | 14 | 2020 | 1543 | 1.230 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2020 | 788 | 1.210 |
Why?
|
| Sequence Analysis, DNA | 6 | 2019 | 866 | 1.160 |
Why?
|
| Kidney Neoplasms | 9 | 2021 | 635 | 1.040 |
Why?
|
| Neoplasm, Residual | 3 | 2019 | 181 | 0.940 |
Why?
|
| DNA Mutational Analysis | 8 | 2019 | 529 | 0.850 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 726 | 0.700 |
Why?
|
| Thyroid Neoplasms | 6 | 2020 | 424 | 0.650 |
Why?
|
| Database Management Systems | 1 | 2018 | 41 | 0.610 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 34 | 0.610 |
Why?
|
| Medical Informatics | 1 | 2018 | 49 | 0.600 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2016 | 5 | 0.550 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2021 | 185 | 0.520 |
Why?
|
| INDEL Mutation | 1 | 2015 | 31 | 0.520 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2020 | 54 | 0.480 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 2014 | 0.470 |
Why?
|
| Gene Fusion | 3 | 2017 | 39 | 0.430 |
Why?
|
| Adenoma | 3 | 2020 | 246 | 0.430 |
Why?
|
| Middle Aged | 37 | 2021 | 25865 | 0.430 |
Why?
|
| Dermatomyositis | 2 | 2009 | 18 | 0.430 |
Why?
|
| Computational Biology | 1 | 2015 | 542 | 0.400 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 344 | 0.390 |
Why?
|
| Humans | 55 | 2021 | 89073 | 0.380 |
Why?
|
| Aged | 28 | 2021 | 19078 | 0.380 |
Why?
|
| Adult | 32 | 2021 | 26508 | 0.370 |
Why?
|
| Carcinoma, Papillary | 3 | 2018 | 159 | 0.370 |
Why?
|
| Pyrimidines | 3 | 2018 | 372 | 0.360 |
Why?
|
| Telomerase | 2 | 2020 | 62 | 0.350 |
Why?
|
| Parvovirus B19, Human | 1 | 2009 | 3 | 0.340 |
Why?
|
| Parvoviridae Infections | 1 | 2009 | 6 | 0.340 |
Why?
|
| Translocation, Genetic | 4 | 2020 | 266 | 0.340 |
Why?
|
| Melanoma | 3 | 2019 | 467 | 0.340 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2020 | 53 | 0.340 |
Why?
|
| Herpesvirus 2, Human | 1 | 2009 | 45 | 0.340 |
Why?
|
| Melanins | 3 | 2017 | 23 | 0.320 |
Why?
|
| Limit of Detection | 2 | 2019 | 20 | 0.320 |
Why?
|
| Immunohistochemistry | 11 | 2021 | 1796 | 0.300 |
Why?
|
| Herpes Simplex | 1 | 2009 | 203 | 0.300 |
Why?
|
| Female | 36 | 2021 | 46014 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2019 | 2335 | 0.300 |
Why?
|
| Male | 32 | 2021 | 42254 | 0.300 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 1194 | 0.300 |
Why?
|
| Endometrial Neoplasms | 2 | 2019 | 205 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 616 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2021 | 287 | 0.260 |
Why?
|
| Pyrazoles | 2 | 2017 | 150 | 0.260 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2005 | 5 | 0.260 |
Why?
|
| Hematologic Neoplasms | 2 | 2020 | 342 | 0.260 |
Why?
|
| Microdissection | 1 | 2005 | 18 | 0.250 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2017 | 307 | 0.250 |
Why?
|
| Lasers | 1 | 2005 | 107 | 0.250 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 6777 | 0.240 |
Why?
|
| Young Adult | 10 | 2020 | 6289 | 0.230 |
Why?
|
| Gene Frequency | 4 | 2019 | 685 | 0.220 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 754 | 0.220 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2020 | 55 | 0.210 |
Why?
|
| Software | 2 | 2018 | 665 | 0.210 |
Why?
|
| Phenotype | 8 | 2021 | 2439 | 0.210 |
Why?
|
| Lymphoma, Mantle-Cell | 2 | 2020 | 37 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2020 | 412 | 0.200 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2019 | 41 | 0.200 |
Why?
|
| Eosinophilia | 2 | 2020 | 84 | 0.190 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2020 | 9 | 0.190 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 2020 | 5 | 0.190 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 65 | 0.190 |
Why?
|
| beta Catenin | 2 | 2019 | 266 | 0.190 |
Why?
|
| Biopsy | 5 | 2020 | 1182 | 0.180 |
Why?
|
| Remission Induction | 2 | 2020 | 740 | 0.180 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 981 | 0.180 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2021 | 62 | 0.180 |
Why?
|
| Hematology | 1 | 2020 | 30 | 0.180 |
Why?
|
| Chromothripsis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2020 | 24 | 0.180 |
Why?
|
| Aminopyridines | 1 | 2020 | 40 | 0.170 |
Why?
|
| Mitoxantrone | 1 | 2020 | 68 | 0.170 |
Why?
|
| Transcription Factors | 4 | 2021 | 1652 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 133 | 0.170 |
Why?
|
| DNA-Binding Proteins | 4 | 2021 | 1241 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2020 | 80 | 0.170 |
Why?
|
| Triazines | 1 | 2020 | 53 | 0.170 |
Why?
|
| Recurrence | 2 | 2019 | 1140 | 0.170 |
Why?
|
| Eosinophils | 1 | 2020 | 194 | 0.170 |
Why?
|
| Endometrial Hyperplasia | 1 | 2019 | 11 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 112 | 0.170 |
Why?
|
| Loss of Heterozygosity | 1 | 2019 | 86 | 0.170 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 66 | 0.170 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 147 | 0.170 |
Why?
|
| Microsatellite Instability | 1 | 2019 | 49 | 0.160 |
Why?
|
| Syk Kinase | 1 | 2018 | 6 | 0.160 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2018 | 154 | 0.160 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2018 | 8 | 0.160 |
Why?
|
| Janus Kinases | 1 | 2018 | 23 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 136 | 0.160 |
Why?
|
| Sulfones | 1 | 2018 | 45 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2018 | 604 | 0.160 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2019 | 49 | 0.160 |
Why?
|
| Stromal Cells | 1 | 2019 | 151 | 0.160 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 16 | 0.160 |
Why?
|
| Thyroid Nodule | 1 | 2019 | 58 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 161 | 0.160 |
Why?
|
| Biomarkers | 1 | 2005 | 1755 | 0.160 |
Why?
|
| Cancer Vaccines | 1 | 2019 | 160 | 0.150 |
Why?
|
| Neoplasms | 3 | 2019 | 3035 | 0.150 |
Why?
|
| Coinfection | 1 | 2018 | 61 | 0.150 |
Why?
|
| Organoids | 1 | 2018 | 62 | 0.150 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 132 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 294 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1265 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 204 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1975 | 0.150 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 25 | 0.150 |
Why?
|
| Genetic Testing | 2 | 2019 | 537 | 0.150 |
Why?
|
| Gene Amplification | 1 | 2018 | 134 | 0.150 |
Why?
|
| Prognosis | 6 | 2021 | 3773 | 0.150 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 106 | 0.150 |
Why?
|
| Octamer Transcription Factors | 1 | 2017 | 5 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2018 | 156 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 103 | 0.150 |
Why?
|
| Chromosomes, Human, X | 1 | 2017 | 55 | 0.150 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2017 | 13 | 0.150 |
Why?
|
| Nose Neoplasms | 1 | 2017 | 31 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 195 | 0.140 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2017 | 14 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2019 | 211 | 0.140 |
Why?
|
| Autophagy | 1 | 2019 | 159 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 37 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 281 | 0.140 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 2347 | 0.140 |
Why?
|
| Nasal Mucosa | 1 | 2017 | 191 | 0.140 |
Why?
|
| Blood Donors | 1 | 2016 | 22 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2016 | 50 | 0.140 |
Why?
|
| Monosomy | 1 | 2016 | 12 | 0.140 |
Why?
|
| Glioma | 1 | 2019 | 293 | 0.140 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2016 | 3 | 0.140 |
Why?
|
| Glycogen Storage Disease | 1 | 2016 | 5 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2018 | 261 | 0.140 |
Why?
|
| Benchmarking | 1 | 2016 | 79 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2020 | 9003 | 0.140 |
Why?
|
| Reference Standards | 1 | 2016 | 144 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2016 | 85 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 128 | 0.130 |
Why?
|
| Skin | 2 | 2009 | 581 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 177 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2019 | 200 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 157 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 261 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 889 | 0.130 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2752 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2018 | 323 | 0.120 |
Why?
|
| Sexual and Gender Minorities | 1 | 2018 | 205 | 0.120 |
Why?
|
| Sarcoma | 1 | 2017 | 220 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 258 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 162 | 0.120 |
Why?
|
| Genomics | 2 | 2018 | 761 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 763 | 0.120 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2014 | 5 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2019 | 669 | 0.120 |
Why?
|
| Hair Follicle | 1 | 2013 | 28 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 49 | 0.110 |
Why?
|
| Molecular Motor Proteins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Myosin Heavy Chains | 1 | 2014 | 91 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 1591 | 0.110 |
Why?
|
| Neoplasm Grading | 3 | 2019 | 372 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2020 | 354 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 781 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2019 | 1371 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 667 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 575 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 395 | 0.100 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2011 | 31 | 0.100 |
Why?
|
| Liver | 2 | 2021 | 1205 | 0.100 |
Why?
|
| Stem Cells | 1 | 2013 | 372 | 0.090 |
Why?
|
| Nose Diseases | 1 | 2009 | 11 | 0.090 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2009 | 5 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2010 | 79 | 0.090 |
Why?
|
| HIV Infections | 1 | 2018 | 835 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2009 | 72 | 0.080 |
Why?
|
| Mice | 6 | 2018 | 11742 | 0.080 |
Why?
|
| Adolescent | 5 | 2020 | 9237 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2009 | 299 | 0.080 |
Why?
|
| Germ Cells | 2 | 2020 | 130 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1114 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2009 | 314 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2009 | 173 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2009 | 466 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2009 | 210 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 259 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1650 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1875 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 249 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2018 | 146 | 0.070 |
Why?
|
| Nephrectomy | 2 | 2020 | 293 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 1096 | 0.070 |
Why?
|
| Adenine | 2 | 2017 | 88 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2019 | 3374 | 0.070 |
Why?
|
| Alleles | 2 | 2020 | 1135 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 1108 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2018 | 502 | 0.070 |
Why?
|
| Animals | 7 | 2018 | 27324 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1990 | 0.060 |
Why?
|
| Piperidines | 2 | 2017 | 164 | 0.060 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Prevalence | 2 | 2020 | 1240 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2019 | 1533 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2005 | 96 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 258 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2005 | 140 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 313 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 122 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1715 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2005 | 691 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 887 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 8203 | 0.050 |
Why?
|
| Lung | 1 | 2009 | 1258 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 3211 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2863 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 511 | 0.050 |
Why?
|
| SMARCB1 Protein | 1 | 2021 | 13 | 0.050 |
Why?
|
| Neurons | 1 | 2010 | 1580 | 0.050 |
Why?
|
| Keratin-20 | 1 | 2020 | 7 | 0.050 |
Why?
|
| Keratin-7 | 1 | 2020 | 10 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 556 | 0.050 |
Why?
|
| Vimentin | 1 | 2020 | 46 | 0.050 |
Why?
|
| Clathrin Heavy Chains | 1 | 2020 | 4 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2021 | 127 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2021 | 84 | 0.050 |
Why?
|
| Biology | 1 | 2020 | 52 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 111 | 0.040 |
Why?
|
| Telomere | 1 | 2020 | 114 | 0.040 |
Why?
|
| Ipilimumab | 1 | 2019 | 61 | 0.040 |
Why?
|
| Cytarabine | 1 | 2020 | 219 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 139 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 55 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2019 | 10 | 0.040 |
Why?
|
| Azacitidine | 1 | 2020 | 146 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 117 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2019 | 109 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2019 | 152 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2005 | 2011 | 0.040 |
Why?
|
| Everolimus | 1 | 2019 | 40 | 0.040 |
Why?
|
| Greece | 1 | 2018 | 19 | 0.040 |
Why?
|
| Retreatment | 1 | 2019 | 108 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 51 | 0.040 |
Why?
|
| Mouth | 1 | 2018 | 48 | 0.040 |
Why?
|
| Class II Phosphatidylinositol 3-Kinases | 1 | 2018 | 9 | 0.040 |
Why?
|
| HIV | 1 | 2018 | 48 | 0.040 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2018 | 5 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 170 | 0.040 |
Why?
|
| Penis | 1 | 2018 | 60 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 164 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 2017 | 23 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2018 | 115 | 0.040 |
Why?
|
| Keratins | 1 | 2017 | 63 | 0.040 |
Why?
|
| Anal Canal | 1 | 2018 | 88 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2018 | 261 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 74 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 94 | 0.040 |
Why?
|
| ras Proteins | 1 | 2018 | 130 | 0.040 |
Why?
|
| Burkitt Lymphoma | 1 | 2017 | 32 | 0.040 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 24 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2016 | 15 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 682 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2018 | 280 | 0.040 |
Why?
|
| Melanocytes | 1 | 2017 | 57 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2016 | 45 | 0.030 |
Why?
|
| Lymphoma, Follicular | 1 | 2017 | 73 | 0.030 |
Why?
|
| Phosphofructokinases | 1 | 2016 | 2 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2016 | 108 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2016 | 76 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 159 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 421 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 267 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 107 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 166 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 859 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 599 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 165 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 470 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 779 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 1145 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 232 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 459 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 628 | 0.030 |
Why?
|
| Chicago | 1 | 2019 | 1423 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 921 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1940 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 969 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 447 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 1097 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 738 | 0.030 |
Why?
|
| Skin Aging | 1 | 2013 | 29 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 1848 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3657 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 127 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2013 | 103 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1706 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 357 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2062 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 2327 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 376 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1043 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 665 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2017 | 410 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1429 | 0.030 |
Why?
|
| Hyalin | 1 | 2011 | 1 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1521 | 0.030 |
Why?
|
| Thyroglobulin | 1 | 2011 | 59 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 105 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1215 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 198 | 0.020 |
Why?
|
| Hypothalamic Hormones | 1 | 2010 | 2 | 0.020 |
Why?
|
| Orexins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Pituitary Hormones | 1 | 2010 | 7 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2010 | 32 | 0.020 |
Why?
|
| Turbinates | 1 | 2009 | 11 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1363 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2399 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2362 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2009 | 50 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2010 | 114 | 0.020 |
Why?
|
| Brain Stem | 1 | 2010 | 167 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 309 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1157 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2009 | 184 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 2552 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2880 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5466 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 387 | 0.020 |
Why?
|
| United States | 1 | 2019 | 6957 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Child | 1 | 2016 | 7149 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2412 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 1764 | 0.010 |
Why?
|